… advances in prophylaxis and management of venous thromboembolism (VTE), there are a
… was to describe trends in the incidence rates, clinical profile, management, and outcomes for …

… Limited observational data are available on the use of nonvitamin K antagonist oral
anticoagulants (NOACs) for the treatment of acute venous thromboembolism (VTE) in clinical practice…

Background Venous thromboembolism (VTE) is a clinically significant complication that is
well documented among Caucasian cancer patients. However, evidence regarding VTE …

Objectives Venous thromboembolism (VTE) is a major cause of mortality and morbidity
worldwide. This study describes a real-world scenario of VTE presenting to a tertiary care …

… Occurrence of venous thromboembolic events was significantly higher in LA positive patients
compared to LA negative patients (4/9 vs. 5/61, p = 0.002), especially in the first year after …

… of lower extremity thrombophlebitis [23, 25, 26]. In summary, venous thromboembolism
represents … Biological factors appear to be more significant than clinical factors in determining the …

… clinical profile, risk factors, and the clinical outcomes in VTE patients presenting to a
single tertiary care center to rapidly detect the disease and use appropriate thrombo-prophylaxis. …

… Since venous thromboembolism is considered as one single disease entity, it is assumed …
risk factor profiles in patients with different clinical manifestations of venous thromboembolism. …

… -19 patients to a higher incidence of venous thromboembolism (VTE) have been described.
Severe COVID-19 clinical presentation, characterized by acute respiratory distress syndrome…

… that different clinical profiles with regard to venous thromboembolic-related … venous
thromboembolism management by clinicians. Similar figures in the rates of venous thromboembolic …